COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL)

Historical Holders from Q2 2015 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
COLL on Nasdaq
Shares outstanding
31,604,526
Price per share
$46.30
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
36,973,408
Holdings value
$1,293,405,685
% of all portfolios
0%
Share change
+1,037,374
Value change
+$40,664,112
Average buys %
+0%
Average sells %
-0%
Number of holders
241
Price from insider filings
$48.66
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 16% $131,442,850 4,997,827 BlackRock, Inc. 31 Mar 2025
Rubric Capital Management LP 9.3% +29% $78,900,000 +$17,095,000 3,000,000 +28% Rubric Capital Management LP 31 Mar 2025
RENAISSANCE TECHNOLOGIES LLC 5.1% +4.8% $55,955,623 +$2,729,885 1,599,189 +5.1% Renaissance Technologies LLC 08 Sep 2025
Invesco Ltd. 4.9% -10% $43,821,683 -$5,278,081 1,584,871 -11% Invesco Ltd. 30 Jun 2025
PRINCIPAL GLOBAL INVESTORS 4.6% $40,548,891 1,466,506 PRINCIPAL GLOBAL INVESTORS 30 Jun 2025
Pacer Advisors, Inc. 1.1% -87% $11,021,699 -$45,325,814 419,076 -80% Pacer Advisors, Inc. 31 Mar 2025
As of 30 Sep 2025, COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 241 institutional shareholders filing 13F forms. They hold 36,973,408 shares .

Top 25 institutional shareholders own 90% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
BlackRock, Inc. 16% 5,178,044 -3.1% 0% $181,179,760
Rubric Capital Management LP 8.9% 2,826,498 -10% 1.3% $98,899,165
EVENTIDE ASSET MANAGEMENT, LLC 7.6% 2,390,912 -9.5% 1.4% $83,653,116
VANGUARD GROUP INC 7% 2,226,378 -0.97% 0% $77,900,966
RENAISSANCE TECHNOLOGIES LLC 5.1% 1,599,189 +5.1% 0.07% $55,955,623
FULLER & THALER ASSET MANAGEMENT, INC. 4.8% 1,502,674 +5% 0.18% $52,578,565
PRINCIPAL FINANCIAL GROUP INC 4.1% 1,309,771 -11% 0.02% $45,828,887
STATE STREET CORP 4.1% 1,293,911 -4.5% 0% $45,273,946
Invesco Ltd. 4.1% 1,282,971 -19% 0.01% $44,891,155
JANUS HENDERSON GROUP PLC 2.9% 910,241 +94% 0.01% $31,830,414
GEODE CAPITAL MANAGEMENT, LLC 2.6% 836,381 +7.2% 0% $29,268,905
DIMENSIONAL FUND ADVISORS LP 2.6% 831,091 -3.5% 0.01% $29,078,391
GOLDMAN SACHS GROUP INC 2.5% 802,234 +239% 0% $28,070,168
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 2.5% 793,934 -0.66% 0.01% $27,779,750
MORGAN STANLEY 2.4% 767,420 +25% 0% $26,852,063
EMERALD ADVISERS, LLC 2% 639,694 -24% 0.72% $22,382,893
VICTORY CAPITAL MANAGEMENT INC 1.5% 479,672 -5.7% 0.01% $16,783,724
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1.3% 406,849 +5.4% 0% $14,235,647
EMERALD MUTUAL FUND ADVISERS TRUST 1.3% 395,661 -28% 0.71% $13,844,178
D. E. Shaw & Co., Inc. 1.2% 389,775 +91% 0.01% $13,638,227
NORTHERN TRUST CORP 1.2% 371,316 -2.5% 0% $12,992,347
LSV ASSET MANAGEMENT 1.1% 346,600 -0.94% 0.03% $12,128,000
Qube Research & Technologies Ltd 1% 320,559 +238% 0.02% $11,216,359
LOOMIS SAYLES & CO L P 1% 317,880 -5.7% 0.01% $11,122,621
ROYCE & ASSOCIATES LP 0.97% 306,140 +0.11% 0.11% $10,711,839

Institutional Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 533,970 $24,723,026 +$14,107,049 $46.30 6
2025 Q3 36,973,408 $1,293,405,685 +$40,664,112 $34.99 241
2025 Q2 35,739,346 $1,056,745,851 -$27,671,388 $29.57 221
2025 Q1 36,773,847 $1,097,284,840 -$11,471,991 $29.85 241
2024 Q4 37,138,444 $1,064,290,423 -$54,468,002 $28.65 238
2024 Q3 38,489,790 $1,486,827,070 -$25,883,162 $38.64 249
2024 Q2 39,635,493 $1,276,473,897 -$75,941,301 $32.20 230
2024 Q1 15,750,936 $611,334,781 +$3,438,718 $38.82 104
2023 Q4 52,417 $1,613,395 +$1,171,025 $30.78 2
2023 Q3 38,712,095 $865,244,961 -$13,178,970 $22.35 173
2023 Q2 39,246,501 $843,481,931 +$2,463,823 $21.49 177
2023 Q1 39,049,844 $936,806,082 +$74,127,310 $23.99 196
2022 Q4 35,906,853 $833,041,379 +$6,703,744 $23.20 170
2022 Q3 35,377,547 $566,793,335 -$19,963,955 $16.02 152
2022 Q2 36,028,460 $638,405,750 +$14,263,565 $17.72 149
2022 Q1 35,803,978 $728,302,682 +$7,114,275 $20.36 158
2021 Q4 35,563,582 $664,317,744 -$14,377,393 $18.68 148
2021 Q3 36,398,944 $718,585,752 -$38,978,309 $19.74 149
2021 Q2 37,960,763 $897,445,585 -$28,765 $23.64 154
2021 Q1 38,008,378 $900,688,845 +$56,351,929 $23.70 161
2020 Q4 35,813,390 $717,599,768 -$715,810 $20.03 132
2020 Q3 37,272,476 $776,063,717 +$4,076,533 $20.82 136
2020 Q2 36,972,523 $646,887,854 +$3,795,644 $17.50 148
2020 Q1 36,853,640 $601,768,993 +$85,111,412 $16.33 154
2019 Q4 31,480,344 $647,938,114 +$50,515,665 $20.58 133
2019 Q3 30,030,196 $344,731,286 -$4,714,137 $11.48 116
2019 Q2 30,308,774 $398,519,075 -$8,932,302 $13.15 124
2019 Q1 30,822,621 $466,700,688 -$36,652,187 $15.14 136
2018 Q4 33,030,559 $566,650,154 +$7,941,413 $17.17 115
2018 Q3 30,403,113 $448,166,289 +$12,037,917 $14.74 117
2018 Q2 29,122,301 $694,499,813 +$15,808,721 $23.85 127
2018 Q1 30,253,387 $772,950,896 +$49,274,958 $25.55 133
2017 Q4 28,485,885 $526,126,077 +$70,752,202 $18.46 99
2017 Q3 26,039,739 $273,144,788 +$14,179,077 $10.49 74
2017 Q2 24,547,132 $307,089,409 +$19,594,996 $12.51 68
2017 Q1 23,326,686 $234,639,241 +$9,382,943 $10.06 79
2016 Q4 23,305,763 $362,915,530 +$115,650,083 $15.57 85
2016 Q3 15,858,068 $305,526,967 +$29,351,722 $19.26 70
2016 Q2 14,621,309 $173,206,771 -$10,804,125 $11.85 72
2016 Q1 14,863,223 $268,516,234 +$53,136,956 $18.15 68
2015 Q4 11,882,425 $326,622,223 +$13,542,137 $27.50 57
2015 Q3 8,691,692 $192,169,468 +$22,978,059 $22.11 44
2015 Q2 9,280,769 $165,466,756 +$137,896,751 $17.84 45